Chiasma
Employee Participants0
Total Rating0
Revenue$0
At Chiasma, we remain resilient in the face of challenges. Leveraging our delivery technology, Transient Permeability Enhancer (TPE®), we work every day to create innovative solutions to improve the lives of patients with rare or serious diseases. It is our mission to develop and commercialize alternative treatment options to injectable therapies so that we may provide the patients we serve with greater independence to live their lives as they choose. Read More
Headquarters Institute for Innovation in Biotechnology The University of Auckland, Waltham, MA, USA
Website http://www.chiasmapharma.com
0/100